BioXcel Therapeutics Inc (NASDAQ:BTAI)

12.11
Delayed Data
As of Jun 24
 +0.05 / +0.41%
Today’s Change
8.80
Today|||52-Week Range
36.49
-40.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-636.0K-2.1M-4.5M-19.3M
 
 
 
 
 
Depreciation--0.001.0K17.0K
 
 
 
Total Other Cash Flow182.0K671.0K1.6M3.1M
 
 
 
 
 
Funds From Operations-454.0K-1.4M-2.9M-16.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-174.0K-155.0K-736.0K-2.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-280.0K-1.3M-2.2M-13.5M
 
 
 
 
 
 
InvestingCapital Expenditures-1.0K-4.0K0.00-340.0K
 
 
 
 
Net Cash Flow Investing-1.0K-4.0K0.00-340.0K
 
 
 
 
 
FinancingShort Term Borrowings0.000.00371.0K-371.0K
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale281.0K1.3M2.3M56.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00507.0K--
 
 
Other Uses - Financing0.000.0070.0K622.0K
 
 
 
Net Cash Flow - Financing281.0K1.3M3.1M55.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash0.000.00887.0K41.7M